Acceleron Pharma Inc (OQ:XLRN)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for XLRN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET July 21st, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jul 17/19 Jul 16/19 Veness Adam M Direct Ownership Common Stock S - Open market or private sale -538 $40.71
Jul 11/19 Jul 9/19 Quisel John D Direct Ownership Option to Purchase Common Stock M - Exercise or conversion exempt under rule 16b-3 -1,562  
Jul 11/19 Jul 9/19 Quisel John D Direct Ownership Option to Purchase Common Stock M - Exercise or conversion exempt under rule 16b-3 -2,346  
Jul 11/19 Jul 9/19 Quisel John D Direct Ownership Option to Purchase Common Stock M - Exercise or conversion exempt under rule 16b-3 -5,000  
Jul 11/19 Jul 9/19 Quisel John D Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 1,562 $7.12
Jul 11/19 Jul 9/19 Quisel John D Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,346 $5.28
Jul 11/19 Jul 9/19 Quisel John D Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 5,000 $3.88
Jun 28/19 Jun 28/19 George Jean Indirect Ownership Common Stock S - Open market or private sale -11,812 $41.17
Jun 28/19 Jun 26/19 George Jean Direct Ownership Option to Purchase Common Stock M - Exercise or conversion exempt under rule 16b-3 -10,000  
Jun 28/19 Jun 26/19 George Jean Direct Ownership Option to Purchase Common Stock M - Exercise or conversion exempt under rule 16b-3 -20,000  
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for XLRN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET July 21st, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jul 17/19 Jul 16/19 Veness Adam M Direct Ownership Common Stock S - Open market or private sale -538 $40.71
Jul 11/19 Jul 9/19 Quisel John D Direct Ownership Option to Purchase Common Stock M - Exercise or conversion exempt under rule 16b-3 -1,562  
Jul 11/19 Jul 9/19 Quisel John D Direct Ownership Option to Purchase Common Stock M - Exercise or conversion exempt under rule 16b-3 -2,346  
Jul 11/19 Jul 9/19 Quisel John D Direct Ownership Option to Purchase Common Stock M - Exercise or conversion exempt under rule 16b-3 -5,000  
Jul 11/19 Jul 9/19 Quisel John D Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 1,562 $7.12
Jul 11/19 Jul 9/19 Quisel John D Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,346 $5.28
Jul 11/19 Jul 9/19 Quisel John D Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 5,000 $3.88
Jun 28/19 Jun 26/19 George Jean Direct Ownership Option to Purchase Common Stock M - Exercise or conversion exempt under rule 16b-3 -10,000  
Jun 28/19 Jun 26/19 George Jean Direct Ownership Option to Purchase Common Stock M - Exercise or conversion exempt under rule 16b-3 -20,000  
Jun 28/19 Jun 28/19 George Jean Indirect Ownership Common Stock S - Open market or private sale -11,812 $41.17
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $XLRN

StockTwits